ANTERIX INC 03676C100 US03676C1009 BBG0081NLHR0 8/6/2024 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 260513 0 FOR 260513 FOR ROIVANT SCIENCES LTD G76279101 BMG762791017 BBG007STW2B8 9/10/2024 To cast a non-binding, advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 66719779 0 FOR 66719779 FOR ROIVANT SCIENCES LTD G76279101 BMG762791017 BBG007STW2B8 9/10/2024 To cast a non-binding, advisory vote on the frequency of future non-binding, advisory votes to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 66719779 0 1 YEAR 66719779 FOR BLUEBIRD BIO INC 09609G209 US09609G2093 BBG00YPS1Z70 12/4/2024 The approval, on a non-binding, advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 557 0 ABSTAIN 557 FOR WHITEHAWK THERAPEUTICS INC 00032Q104 US00032Q1040 BBG002WN7DT2 2/28/2025 Non-Binding Advisory Vote on Golden Parachutes Proposal: To approve, on a non-binding, advisory basis, certain compensation that will or may become payable to our named executive officers in connection with the Divestiture. SECTION 14A SAY-ON-PAY VOTES ISSUER 2282731 0 FOR 2282731 FOR NELNET INC 64031N108 US64031N1081 BBG000PYJY93 5/15/2025 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 163431 0 FOR 163431 FOR BIOMARIN PHARMACEUTICAL INC 09061G101 US09061G1013 BBG000CZWZ05 5/20/2025 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 243 0 ABSTAIN 243 FOR NEXSTAR MEDIA GROUP INC 65336K103 US65336K1034 BBG000DZJVH0 6/17/2025 As required by Section 14A of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Board of Directors is asking stockholders to cast an advisory, non-binding vote to approve the compensation of our Named Executive Officers, as disclosed in this Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 14434 0 FOR 14434 FOR INFORMATICA INC 45674M101 US45674M1018 BBG01LFP9XK6 6/18/2025 Advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 5338 0 ABSTAIN 5338 FOR NVIDIA CORPORATION 67066G104 US67066G1040 BBG000BBJQV0 6/25/2025 Advisory approval of our executive compensation. Key Changes for Fiscal 2025 - CEO Cash Compensation Adjustments: increased base salary and variable cash opportunity to align with peers and for internal pay equity, after years without changes - Increased Target Equity Opportunities for All NEOs - Equity Mix Shift for NEOs Other than CEO: adjusted allocation of target equity across RSUs, SY PSUs, and MY PSUs for NEOs other than Mr. Huang from 40%, 55%, and 5% in Fiscal 2024 to 50%, 25%, and 25% in Fiscal 2025, respectively, to emphasize long term performance incentives while encouraging retention - Further Increased Rigor of Performance Goals SECTION 14A SAY-ON-PAY VOTES ISSUER 1086 0 ABSTAIN 1086 FOR MONGODB, INC 60937P106 US60937P1066 BBG0022FDRY8 6/30/2025 Approval, on a non-binding advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 246 0 FOR 246 FOR MONGODB, INC 60937P106 US60937P1066 BBG0022FDRY8 6/30/2025 Approval, on a non-binding advisory basis, of the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 246 0 1 YEAR 246 FOR